Back to search

Article

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohort

2025-06-29

Abstract excerpt

<title>Abstract</title> <p> Highly sensitive plasma assays enable accurate blood-based biomarkers for neurodegenerative disease and provide minimally invasive options for clinical use. Large-scale studies encompassing multiple neurodegenerative diseases and utilizing multiplex platforms are essential to uncover disease-specific biomarkers and pathways. We generated and analyzed plasma proteomics using the NULISA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80cdee2f-319a-55ea-b96d-f753846a30a1
DOI
10.21203/rs.3.rs-6440485/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortDOI 10.21203/rs.3.rs-6440485/v1
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity
Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity
Deep Plasma Proteomics Reveals Shared and Disease-Specific Molecular Signatures in Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity
Plasma vs. serum: which is better for proteomic blood biomarker analysis? Evaluation of the novel NULISA platformSemantic proximity
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumSemantic proximity
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaSemantic proximity
Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathologySemantic proximity
Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity
Plasma and CSF proteomic signatures related to Alzheimer’s, α-synuclein, or vascular pathologies and clinical declineSemantic proximity
Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseasesSemantic proximity
Multi-tissue proteomic signatures of Alzheimer’s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tearsSemantic proximity
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s diseaseSemantic proximity
Select a neighboring publication to make it the new centre.